FCP
GILD icon

Fidelis Capital Partners’s Gilead Sciences GILD Stock Holding History

Fidelis Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$794K Buy
5,697
+505
+10% +$70.7K 0.06% 244
2025
Q4 		$637K Buy
5,192
+206
+4% +$25K 0.05% 269
2025
Q3 		$553K Sell
4,986
-305
-6% -$34.7K 0.04% 281
2025
Q2 		$583K Buy
5,291
+575
+12% +$61.2K 0.05% 239
2025
Q1 		$487K Buy
4,716
+7
+0.1% +$722 0.05% 251
2024
Q4 		$463K Buy
4,709
+215
+5% +$19.4K 0.05% 266
2024
Q3 		$392K Buy
4,494
+268
+6% +$20.4K 0.05% 274
2024
Q2 		$313K Buy
4,226
+1,201
+40% +$80.1K 0.04% 280
2024
Q1 		$222K Buy
3,025
+500
+20% +$38.4K 0.03% 337
2023
Q4 		$205K Buy
+2,525
New +$196K 0.05% 313

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelis Capital Partners's GILD Position: Q1 2026 in Review

Fidelis Capital Partners increased its Gilead Sciences (GILD) stake by 9.7% in Q1 2026, buying an estimated $70.7K and bringing the position to 5,697 shares worth $794K. The position accounts for 0.06% of the portfolio, ranked #244.

Fidelis Capital Partners first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Fidelis Capital Partners held 5,697 shares of Gilead Sciences worth $794K as of Q1 2026.
  • Fidelis Capital Partners bought 505 Gilead Sciences shares in Q1 2026, an estimated $70.7K.
  • Gilead Sciences made up 0.06% of Fidelis Capital Partners's portfolio in Q1 2026, its #244 holding.
  • Fidelis Capital Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.